Stolbrink M.Chinouya M.J.Jayasooriya S.Nightingale R.Evans-Hill L.Allan K.Allen H.Balen J.Beacon T.Bissell K.Chakaya J.Chiang C-Y.Cohen M.Devereux G.El Sony A.Halpin D.M.G.Hurst J.R.Kiprop C.Lawson A.Macé C.Makhanu A.Makokha P.Masekela R.Meme H.Khoo E.M.Nantanda R.Pasternak S.Perrin C.Reddel H.Rylance S.Schweikert P.Were C.Williams S.Winders T.Yorgancioglu A.Marks G.B.Mortimer K.2025-04-102025-04-102022http://hdl.handle.net/20.500.14701/45228BACKGROUND: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low- and middle-income countries (LMICs), causing avoidable morbidity and mortality. The International Union Against Tuberculosis and Lung Disease convened a stakeholder meeting on this topic in February 2022. METHODS : Focused group discussions were informed by literature and presentations summarising experiences of obtaining inhaled medicines in LMICs. The virtual meeting was moderated using a topic guide around barriers and solutions to improve access. The thematic framework approach was used for analysis. RESULT S : A total of 58 key stakeholders, including patients, healthcare practitioners, members of national and international organisations, industry and WHO representatives attended the meeting. There were 20 pre-meeting material submissions. The main barriers identified were 1) low awareness of CRDs; 2) limited data on CRD burden and treatments in LMICs; 3) ineffective procurement and distribution networks; and 4) poor communication of the needs of people with CRDs. Solutions discussed were 1) generation of data to inform policy and practice; 2) capacity building; 3) improved procurement mechanisms; 4) strengthened advocacy practices; and 5) a World Health Assembly Resolution. CONC L U S ION: There are opportunities to achieve improved access to affordable, quality-assured inhaled medicines in LMICs through coordinated, multi-stakeholder, collaborative efforts. © 2022 International Union against Tubercul. and Lung Dis.. All rights reserved.Article10.5588/ijtld.22.0270